Cancer Serum Atlas-Supported Precise Pan-Targeted Proteomics Enable Multicancer Detection
Authors:
- 30 December 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 95 (2) , 862-871
Abstract
The wide dynamic range of serum proteome restrained discovery of clinically interested proteins in large cohort studies. Herein, we presented a high-sensitivity, high-throughput, and precise pan-targeted serum proteomic strategy for highly efficient cancer serum proteomic research and biomarker discovery. We constructed a resource of over 2000 cancer-secreted proteins, and the standard MS assays and spectra of at least one synthetic unique peptide per protein were acquired and documented (Cancer Serum Atlas, www.cancerserumatlas.com). Then, the standard peptide-anchored parallel reaction monitoring (SPA-PRM) method was developed with support of the Cancer Serum Atlas, achieving precise quantification of cancer-secreted proteins with high throughput and sensitivity. We directly quantified 325 cancer-related serum proteins in 288 serums of four cancer types (liver, stomach, lung, breast) and controls with the pan-targeted strategy and discovered considerable potential biomarker benefits for early detection of cancer. Finally, a proteomic-based multicancer detection model was built, demonstrating high sensitivity (87.2%) and specificity (100%), with 73.8% localization accuracy for an independent test set. In conclusion, the Cancer Serum Atlas provides a wide range of potential biomarkers that serve as targets and standard assays for systematic and highly efficient serological studies of cancer. The Cancer Serum Atlas-supported pan-targeted proteomic strategy enables highly efficient biomarker discovery and multicancer detection and thus can be a powerful tool for liquid biopsy.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2017YFA0505001, 2020YFE0202200)
- National Natural Science Foundation of China (81827901, 82272174)
- NHC Key Laboratory of Glycoconjugates Research, Fudan University
- Shanghai Municipality (22S31901900)
This publication has 36 references indexed in Scilit:
- Proteomics reveals the effects of sustained weight loss on the human plasma proteomeMolecular Systems Biology, 2016
- Human SRMAtlas: A Resource of Targeted Assays to Quantify the Complete Human ProteomeCell, 2016
- Plasma Proteome Profiling to Assess Human Health and DiseaseCell Systems, 2016
- System-wide Clinical Proteomics of Breast Cancer Reveals Global Remodeling of Tissue HomeostasisCell Systems, 2016
- Quantitative variability of 342 plasma proteins in a human twin populationMolecular Systems Biology, 2015
- Review of Commonly Used Serum Tumor Markers and Their Relevance for Image InterpretationJournal of Computer Assisted Tomography, 2015
- Targeted proteomicsNature Methods, 2013
- Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directionsNature Methods, 2012
- Tumor Markers in Clinical Practice: A Review Focusing on Common Solid CancersMedical Principles and Practice, 2012
- Biomarkers for the lung cancer diagnosis and their advances in proteomicsBMB Reports, 2008